These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

560 related items for PubMed ID: 33138354

  • 1. Maxamycins: Durable Antibiotics Derived by Rational Redesign of Vancomycin.
    Wu ZC, Boger DL.
    Acc Chem Res; 2020 Nov 17; 53(11):2587-2599. PubMed ID: 33138354
    [Abstract] [Full Text] [Related]

  • 2. Peripheral modifications of [Ψ[CH2NH]Tpg4]vancomycin with added synergistic mechanisms of action provide durable and potent antibiotics.
    Okano A, Isley NA, Boger DL.
    Proc Natl Acad Sci U S A; 2017 Jun 27; 114(26):E5052-E5061. PubMed ID: 28559345
    [Abstract] [Full Text] [Related]

  • 3. Vancomycin C-Terminus Guanidine Modifications and Further Insights into an Added Mechanism of Action Imparted by a Peripheral Structural Modification.
    Wu ZC, Cameron MD, Boger DL.
    ACS Infect Dis; 2020 Aug 14; 6(8):2169-2180. PubMed ID: 32598127
    [Abstract] [Full Text] [Related]

  • 4. Total syntheses and initial evaluation of [Ψ[C(═S)NH]Tpg⁴]vancomycin, [Ψ[C(═NH)NH]Tpg⁴]vancomycin, [Ψ[CH₂NH]Tpg⁴]vancomycin, and their (4-chlorobiphenyl)methyl derivatives: synergistic binding pocket and peripheral modifications for the glycopeptide antibiotics.
    Okano A, Nakayama A, Wu K, Lindsey EA, Schammel AW, Feng Y, Collins KC, Boger DL.
    J Am Chem Soc; 2015 Mar 18; 137(10):3693-704. PubMed ID: 25750995
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Total synthesis of [Ψ[C(═NH)NH]Tpg(4)]vancomycin and its (4-chlorobiphenyl)methyl derivative: impact of peripheral modifications on vancomycin analogues redesigned for dual D-Ala-D-Ala and D-Ala-D-Lac binding.
    Okano A, Nakayama A, Schammel AW, Boger DL.
    J Am Chem Soc; 2014 Oct 01; 136(39):13522-5. PubMed ID: 25211770
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Quantum simulations of the structure and binding of glycopeptide antibiotic aglycons to cell wall analogues.
    Lee JG, Sagui C, Roland C.
    J Phys Chem B; 2005 Nov 03; 109(43):20588-96. PubMed ID: 16853665
    [Abstract] [Full Text] [Related]

  • 9. C1-CBP-vancomycin: Impact of a Vancomycin C-Terminus Trimethylammonium Cation on Pharmacological Properties and Insights into Its Newly Introduced Mechanism of Action.
    Wu ZC, Isley NA, Okano A, Weiss WJ, Boger DL.
    J Org Chem; 2020 Feb 07; 85(3):1365-1375. PubMed ID: 31670958
    [Abstract] [Full Text] [Related]

  • 10. Total synthesis of [Ψ[C(═S)NH]Tpg4]vancomycin aglycon, [Ψ[C(═NH)NH]Tpg4]vancomycin aglycon, and related key compounds: reengineering vancomycin for dual D-Ala-D-Ala and D-Ala-D-Lac binding.
    Xie J, Okano A, Pierce JG, James RC, Stamm S, Crane CM, Boger DL.
    J Am Chem Soc; 2012 Jan 18; 134(2):1284-97. PubMed ID: 22188323
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Vancomycin derivatives that inhibit peptidoglycan biosynthesis without binding D-Ala-D-Ala.
    Ge M, Chen Z, Onishi HR, Kohler J, Silver LL, Kerns R, Fukuzawa S, Thompson C, Kahne D.
    Science; 1999 Apr 16; 284(5413):507-11. PubMed ID: 10205063
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.